INDIA Trends and Developments
Trends and Developments Contributed by: Vaibhav Choukse, Ela Bali, Aditi Khanna and Faiz Siddiqui JSA JSA is a leading full-service national firm with more than 700 professionals across eight offices. The com - petition team at JSA has been at the forefront since the inception of India’s competition regime, advising on merger control, cartels (including leniency), abuse of dominance, compliance, and antitrust litigation. The team has secured CCI approvals for numer - ous complex transactions, including ChemChina’s
USD44 billion acquisition of Syngenta, Temasek’s investments in Haldiram Foods, Manipal Hospitals, Cloudnine Hospitals, Romsons Group, API Holdings and VFS Global, EQT’s investment in Indira IVF and HDFC Credila, IBM’s global separation of its MIS Business into Kyndryl, and ONGC NTPC Green’s ac - quisition of Ayana Renewables.
Authors
Vaibhav Choukse is an equity partner in the competition law practice at JSA and widely recognised as one of India’s foremost antitrust lawyers. With over 17 years of experience, he has played a key role in the evolution
Aditi Khanna is a principal associate in JSA’s competition law practice with over eight years’ experience advising on merger control, antitrust litigation and compliance. She has extensive experience in complex domestic and cross-border transactions, including transaction structuring, competition law due diligence, compliance, information-sharing protocols, and obtaining approvals from the CCI. Her sectoral experience includes healthcare, financial services, energy, logistics, technology and manufacturing. Aditi has been recognised by a leading legal directory.
of competition law in India, working with the CCI on drafting rules and regulations. Vaibhav advises on complex antitrust litigation, merger control and compliance, across diverse industries, including advising on Temasek, Alpha Wave and IHC’s investment in Haldiram Foods, EQT’s investments in Indira IVF and HDFC Credila. He is consistently recognised by Chambers and Partners (Asia-Pacific and Global Guides) and other directories.
Faiz Siddiqui is a senior associate at JSA’s competition law practice and has more than six years’ experience advising on merger control, antitrust litigation and compliance. He represents clients across a broad
Ela Bali is a partner at JSA’s competition law practice, with over 12 years’ experience. She represents and advises clients on merger control, antitrust litigation and compliance. Ela has secured CCI approvals for
range of sectors, including healthcare, technology, financial services and food and beverages. Faiz regularly advises on strategic competition law issues, combining strong regulatory insight with practical, commercially focused solutions for both domestic and multinational clients. He has been recognised by a leading legal directory.
complex deals, including ChemChina’s USD44 billion global acquisition of Syngenta. She has been recognised and ranked by Chambers and Partners (Asia-Pacific and Global Guides) – Up and Coming (2025 and 2026), and other directories.
306 CHAMBERS.COM
Powered by FlippingBook